Showing results (2191-2200 of 2,257) with videos related to
Sort By:
Pageof 226
Journal of Neurology, Neurosurgery, and Psychiatry|November 29, 2014
CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysisV Fridman, B Bundy, M M Reilly, et al.Plos Pathogens|June 14, 2022
Ucl fimbriae regulation and glycan receptor specificity contribute to gut colonisation by extra-intestinal pathogenic Escherichia coliSteven J Hancock, Alvin W Lo, Thomas Ve, et al.The American Journal of Tropical Medicine and Hygiene|June 20, 2018
A Pilot Study to Assess Safety and Feasibility of Intrathecal Immunoglobulin for the Treatment of Adults with TetanusHuynh Thi Loan, Lam Minh Yen, Evelyne Kestelyn, et al.Archives of Disease in Childhood|January 1, 1996
The role of Epstein-Barr virus in Hodgkin's disease from different geographical areasM Weinreb, P J Day, F Niggli, et al.Nature Microbiology|September 5, 2018
Publisher Correction: Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidinAngelino T Tromp, Michiel Van Gent, Pauline Abrial, et al.The Lancet. Infectious Diseases|April 27, 2024
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)Phrutsamon Wongnak, William H K Schilling, Podjanee Jittamala, et al.British Journal of Clinical Pharmacology|October 6, 2025
Population pharmacokinetics of artemether-lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malariaJunjie Ding, Richard M Hoglund, Rob W van der Pluijm, et al.Emerging Infectious Diseases|March 20, 2018
Rickettsial Illnesses as Important Causes of Febrile Illness in Chittagong, BangladeshHugh W Kingston, Mosharraf Hossain, Stije Leopold, et al.Journal of Medicinal Chemistry|July 29, 2010
Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug designAndrew J Woodhead, Hayley Angove, Maria G Carr, et al.Science (New York, N.Y.)|July 18, 2024
Artemisinin-resistant malaria in Africa demands urgent actionMehul Dhorda, Akira Kaneko, Ryuichi Komatsu, et al.Pageof 226